Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

D

DNLI

Denali Therapeutics Inc

24.06

Aug 04 • 12:34 PM ET +0.91 (3.93%)

Healthcare Biotechnology USA Mid NASD

Peers: ACAD XENE AXSM BMRN VKTX INCY NBIX MDGL KROS BIIB

| Held by: VTI IWM VB XBI VBK VXF IWN IBB VTWO SCHA

Scroll to Statements

Index	RUT
Market Cap	3.82B
Enterprise Value	2.87B
Income	-508.02M
Sales	0.00M
Book/sh	5.84
Cash/sh	6.22
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	503
IPO	Dec 08, 2017

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	4.12
P/C	3.87
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	9.28
Current Ratio	9.28
Debt/Eq	0.04
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-2.88
EPS next Y	-2.44
EPS next Q	-0.51
EPS this Y	18.92%
EPS next Y	-1.29%
EPS next 5Y	14.77%
EPS past 3/5Y	-4.56% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-7.88%
Sales Y/Y TTM	-100.00%
EPS Q/Q	11.38%
Sales Q/Q	-
Earnings	Aug 06 AMC
EPS/Sales Surpr.	4.60% -100.00%

Insider Own	6.30%
Insider Trans	0.00%
Inst Own	100.89%
Inst Trans	2.92%
ROA	-40.04%
ROE	-49.59%
ROIC	-53.12%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	0.10%
SMA50	4.25%
SMA200	20.81%
Trades

Shs Outstand	158.66M
Shs Float	148.71M
Short Float	10.78%
Short Ratio	8.53
Short Interest	16.04M
52W High	27.30 -11.87%
52W Low	12.58 91.26%
Volatility	4.15% 5.27%
ATR (14)	1.14
RSI (14)	52.20
Beta	1.00
Rel Volume	0.31
Avg Volume	1.88M
Volume	294,224

Perf Week	0.04%
Perf Month	-6.53%
Perf Quarter	28.87%
Perf Half Y	5.80%
Perf YTD	45.73%
Perf Year	66.62%
Perf 3Y	-12.95%
Perf 5Y	-52.71%
Perf 10Y	-
Recom	1.16
Target Price	34.31
Prev Close	23.15
Price	24.06
Change	3.93%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)